Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-15 Sale | 2023-08-17 4:46 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 1,205 | $168.95 | $203,581 | 49,701 (Direct) | View |
| 2023-05-15 Sale | 2023-05-17 4:51 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 1,311 | $83.59 | $109,589 | 46,781 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:59 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 414 | $84.46 | $34,966 | 48,092 (Direct) | View |
| 2023-03-03 Sale | 2023-03-06 4:51 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 2,169 | $87.57 | $189,939 | 48,506 (Direct) | View |
| 2020-11-11 Sale | 2020-11-12 5:03 pm | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 51,429 | $179.37 | $9,224,669 | 63,674 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-26 Disposition | 2023-09-26 4:30 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 416,051 | $0 | 0 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:49 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 4,125 | $0 | 50,906 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 5:12 pm | N/A 2033-01-03 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 79,325 | $0 | 114,325 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:06 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-27 6:36 pm | N/A N/A | PIONEER NATURAL RESOURCES CO | PXD | WORTLEY MICHAEL D Director | 1,456 | $0 | 11,626 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:52 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-11-11 Conversion | 2020-11-12 5:03 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 51,429 | $0 | 63,674 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-12 5:03 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 12,245 | $11 | 63,674 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-12 5:03 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 39,184 | $17.43 | 63,674 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-12 5:03 pm | N/A 2026-05-25 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 51,429 | $0 | 63,674 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-26 4:28 pm | N/A N/A | PIONEER NATURAL RESOURCES CO | PXD | WORTLEY MICHAEL D Director | 2,748 | $0 | 10,170 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 3:12 pm | N/A 2030-01-02 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2019-10-14 Option Award | 2019-11-12 5:49 pm | N/A 2029-01-02 | REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer | 34,500 | $0 | 34,500 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 5:07 pm | N/A N/A | PIONEER NATURAL RESOURCES CO | PXD | WORTLEY MICHAEL D Director | 1,414 | $0 | 7,422 (Direct) | View |